NAROPIN
ASPEN PHARMACARE CANADA INC.
Quick answers
Is there a shortage of NAROPIN in Canada?
No. There is no current shortage of NAROPIN 10MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ROPIVACAINE HYDROCHLORIDE INJECTION, USP
FRESENIUS KABI CANADA LTD
Other Products
NAROPIN
ASPEN PHARMACARE CANADA INC.
ROPIVACAINE HYDROCHLORIDE INJECTION
TEVA CANADA LIMITED
XFUSOR
FORMATIVE PHARMA INC.
NAROPIN INJ 7.5MG/ML
ASTRAZENECA CANADA INC
DIN
02229418
Strength
10MG
Dosage Form
SOLUTION
Route
EPIDURAL
Compare with another product →
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from ASPEN PHARMACARE CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02087286
2MG · DIN 00004715
2.5MG · DIN 02245531
7.5MG · DIN 02258056
2MG · DIN 02493055
10MG · DIN 02018950
300MCG · DIN 02213230
50MCG · DIN 02213192
150MCG · DIN 02213214
100MCG · DIN 02213206
200MCG · DIN 02213222
DIN 00886858